Research Papers

25 of 33721 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Quality assurance procedures during commissioning of a treatment planning system as a tool to establish new standards b…
Bielęda G; Zwierzchowski G; Błasiak B; Skowronek J.
J Contemp Brachytherapy (Unknown)
Published: 2010
Dose volume uniformity index: a simple tool for treatment plan evaluation in brachytherapy.
Prabhakar R.
J Contemp Brachytherapy (Unknown)
Published: 2010
Influence of length of interval between pulses in PDR brachytherapy (PDRBT) on value of Biologically Equivalent Dose (B…
Skowronek J; Malicki J; Zwierzchowski G; Piotrowski T.
J Contemp Brachytherapy (Unknown)
Published: 2010
Interstitial HDR brachytherapy (HDR-BT) in early stage mobile tongue cancers in young patients - Gliwice experience.
Kellas-Ślęczka S; Białas B; Fijałkowski M; Składowski K; Szlag M; Cholewka A.
J Contemp Brachytherapy (Unknown)
Published: 2010
Effectiveness of two different HDR brachytherapy regimens with the same BED value in cervical cancer.
Passi K; Kehwar TS; Mittal M; Singh B; Vashistha R; Gupta SJ; Yakhmi JV.
J Contemp Brachytherapy (Unknown)
Published: 2010
The Influence of Milling on the Dissolution Performance of Simvastatin.
Zimper U; Aaltonen J; Krauel-Goellner K; Gordon KC; Strachan CJ; Rades T.
Pharmaceutics (Unknown)
Published: 2010
1/6 Transparent
Funding Declared
Pediatric Dosing and Body Size in Biotherapeutics.
Shi R; Derendorf H.
Pharmaceutics (Unknown)
Published: 2010
Drug Development for Pediatric Populations: Regulatory Aspects.
Zisowsky J; Krause A; Dingemanse J.
Pharmaceutics (Unknown)
Published: 2010
2/6 Transparent
Funding Declared
Small Volume Dissolution Testing as a Powerful Method during Pharmaceutical Development.
Scheubel E; Lindenberg M; Beyssac E; Cardot JM.
Pharmaceutics (Unknown)
Published: 2010
1/6 Transparent
Enhanced Dissolution and Oral Bioavailability of Piroxicam Formulations: Modulating Effect of Phospholipids.
Mirza S; Miroshnyk I; Habib MJ; Brausch JF; Hussain MD.
Unknown Journal
Published: 2010
1/6 Transparent
Funding Declared
Timing and Duration of Drug Exposure Affects Outcomes of a Drug-Nutrient Interaction During Ontogeny.
Ling B; Aziz C; Wojnarowicz C; Olkowski A; Alcorn J.
Pharmaceutics (Unknown)
Published: 2010
Impact of Oral Fast Release Amantadine on Movement Performance in Patients with Parkinson's Disease.
Muhlack S; Müsch P; Konietzka S; Woitalla D; Przuntek H; Müller T.
Pharmaceutics (Unknown)
Published: 2010
Expression of Drug-Resistant Factor Genes in Hepatocellular Carcinoma Patients Undergoing Chemotherapy with Platinum Co…
Sakurada T; Yoshikawa M; Sunaga M; Kobayashi E; Satoh N; Yokosuka O; Ueda S.
Pharmaceutics (Unknown)
Published: 2010
Tacrolimus Pharmacokinetic and Pharmacogenomic Differences between Adults and Pediatric Solid Organ Transplant Recipien…
Marfo K; Altshuler J; Lu A.
Pharmaceutics (Unknown)
Published: 2010
Effect of Moisture on Powder Flow Properties of Theophylline.
Sandler N; Reiche K; Heinämäki J; Yliruusi J.
Pharmaceutics (Unknown)
Published: 2010
Induction of Drug Transporters Alters Disposition of Risperidone - A Study in Mice.
Holthoewer D; Hiemke C; Schmitt U.
Unknown Journal
Published: 2010
Useful Extend-release Chitosan Tablets with High Antioxidant Activity.
Yasufuku T; Anraku M; Kondo Y; Hata T; Hirose J; Kobayashi N; Tomida H.
Unknown Journal
Published: 2010
The Role of Configurational Entropy in Amorphous Systems.
Graeser KA; Patterson JE; Zeitler JA; Rades T.
Unknown Journal
Published: 2010
2/6 Transparent
Code Funding Declared
A Comparative Study of Transmembrane Diffusion and Permeation of Ibuprofen across Synthetic Membranes Using Franz Diffu…
Ng SF; Rouse J; Sanderson D; Eccleston G.
Pharmaceutics (Unknown)
Published: 2010
1/6 Transparent
Funding Declared
Asymmetric Membrane Capsules for Extended Delivery of the Weakly Basic Drug Carvedilol.
Guarve K; Gupta GD.
Pharmaceutics (Unknown)
Published: 2010
Optimization of Salbutamol Sulfate Dissolution from Sustained Release Matrix Formulations Using an Artificial Neural Ne…
Chaibva F; Burton M; Walker RB.
Pharmaceutics (Unknown)
Published: 2010
1/6 Transparent
Funding Declared
Quantitative Determination of ABT-925 in Human Plasma by On-Line SPE and LC-MS/MS: Validation and Sample Analysis in Ph…
Wan K; Rieser M; El-Shourbagy T.
Pharmaceutics (Unknown)
Published: 2010
Strategies for Developing Sensitive and Automated LC-MS/MS Assays of a Pharmaceutical Compound and Its Metabolite from …
Xu RN; Polzin J; Kranz M; Vaca P; Metchkarova M; Rieser MJ; El-Shourbagy TA.
Pharmaceutics (Unknown)
Published: 2010
Diclofenac Salts. V. Examples of Polymorphism among Diclofenac Salts with Alkyl-hydroxy Amines Studied by DSC and HSM.
Fini A; Cavallari C; Ospitali F.
Pharmaceutics (Unknown)
Published: 2010
Automatic Supported Liquid Extraction (SLE) Coupled with HILIC-MS/MS: An Application to Method Development and Validati…
Pan J; Jiang X; Chen YL.
Pharmaceutics (Unknown)
Published: 2010
1/6 Transparent
Funding Declared